(Binswanger’s Disease; Senile Dementia; Binswanger’s Type; Vascular Cognitive Impairment; Arteriosclerotic Dementia; Atherosclerotic Disease)
|Healthy and Injured Brain Blood Vessels|
|Copyright © Nucleus Medical Media, Inc.|
- Progressive loss of intellectual abilities, processing speed, and cognitive and motor abilities
- Progressive memory loss
- Slow, unsteady walking
- Personality changes
- Laughing, crying, or smiling during inappropriate times
- Difficulty speaking
- Swallowing difficulties
- Paralysis or weakness of one or both sides of the body
- Loss of interest in activities
- Tremors, loss of coordination, loss of trunk mobility
- Nighttime confusion
- Electrocardiogram (ECG)—to measure electrical activity of the heart
- Electroencephalogram (EEG)—to measure electrical activity of the brain
- Neuropsychological testing
- Medications to control:
- Nimodipine—may help improve cognitive function in the short term, but lacks evidence to support its long-term use
- Medications used to treat Alzheimers disease
- If you smoke, talk to your doctor about how you can successfully quit.
- Eat a diet that is low in fat and low in salt.
- If you drink alcohol, do so only in moderation. Moderate alcohol intake is two drinks per day for men; one drink per day for women.
- Have your blood pressure and blood cholesterol levels checked at least once a year.
- If you have diabetes, maintain your blood glucose in your target range.
- Avoid low blood pressure. If you get lightheaded when you stand up, or have a history of fainting, talk to your doctor.
Alzheimer’s Association http://www.alz.org
National Institute of Neurological Disorders and Stroke http://www.ninds.nih.gov
Alzheimer Society of Canada http://www.alzheimer.ca
Heart and Stroke Foundation of Canada http://www.heartandstroke.com
Caplan LR. Binswanger’s disease—revisited. Neurology. 1995;45(4):626-633.
Kirschner H. Vascular dementia: A review of recent evidence for prevention and treatment. Curr Neurol Neurosci Rep. 2009;9(6):437-442.
Roman GC. Brain hypoperfusion: A critical factor in vascular dementia. Neurol Res. 2004;26(5):454-458.
Roman GC, Erkinjuntti T, et al. Subcortical ischaemic vascular dementia. Lancet Neurology. 2002;1(7):426-436.
Smith EE. Leukoariosis and stroke. Stroke. 2010;41(10 Suppl):S139-S143.
Tomassoni D, Lanari A, et al. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies. Clin Exp Hypertens. 2008;30(8):744-766.
Vascular dementia. Alzheimer's Association website. Available at: http://www.alz.org/dementia/vascular-dementia-symptoms.asp. Accessed July 29, 2013.
Vascular dementia. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated July 8, 2013. Accessed July 29, 2013.
Vascular dementia: A resource list. National Institute on Aging website. Available at: https://www.nia.nih.gov/alzheimers/vascular-dementia-resource-list. Accessed July 29, 2013.
9/3/2014 DynaMed's Systematic Literature Surveillance. Available at: http://www.ebscohost.com/dynamed: Wippold FJ, Brown DC, et al. American College of Radiology (ACR) Appropriateness Criteria for dementia and movement disorders. Available at: http://www.acr.org/~/media/ACR/Documents/AppCriteria/Diagnostic/DementiaAndMovementDisorders.pdf. Updated 2014. Accessed September 3, 2014.
- Reviewer: Rimas Lukas, MD
- Review Date: 06/2015 -
- Update Date: 09/03/2014 -